Lung Disease Stocks Advance After Actelion Approached By J&J
November 25, 2016 at 17:04 PM EST
After both Actelion, a Switzerland-based biopharmaceutical company, and drug giant Johnson & Johnson confirmed they were in preliminary discussions regarding a potential transaction.
